Eric Bauza, the voice actor behind the modern-day Bugs Bunny and Daffy Duck, among other iconic animated characters, has died at age 46, according to his family and official health records.
The Emmy Award-winner passed away Sunday from hypertensive cardiovascular disease, according to records from the Los Angeles County Medical Examiner.
Bauza's family said in a statement on his social media pages that he died "suddenly."
During his career, Bauza tallied hundreds of voice acting credits with multiple studios, including Disney, DreamWorks and Cartoon Network.
Eric Bauza attends the 2024 Entertainment Community Fund Gala at Marriott Marquis Theater in New York City, on April 8, 2024. - Marleen Moise/WireImage/Getty Images

#bauza #eric #voice #died

PARIS (AP) — The weekend of riots and looting in France did not spare soccer clubs Marseille and Lille.
The Ligue 1 teams said their shops have been vandalized during the protests against rising living costs and poor conditions in schools. Over half a million mainly peaceful protesters took to the streets on Saturday but small groups of people set fires in the streets and looted businesses in Paris, Lyon, Marseille and other cities.
Marseille said in a statement on Monday the looters caused "significant damage" to its official store located on La Canebière — the southern port city's most famous avenue — which has been temporarily closed.
Up north, Lille's city center store "suffered extensive damage and widespread looting," the club said, adding that the shop will remain closed until further notice.
Lille thanked "everyone who has offered their support over the past few hours — first and foremost, our store employees, but also the many passersby, whether supporters or not, who spontaneously stepped forward to offer their help, practical ****** istance and comfort."

#closed #ligue

Liverpool have developed a reputation for having one of the best academies in world football in recent years.
The club has the ability to show prospective additions a clear pathway to the first-team, and the Reds' senior squad has been littered with academy graduates in recent years.
Trent Alexander-Arnold, Curtis Jones, Harvey Elliott, Conor Bradley, Jarell Quansah and Coaimhin Kelleher are just some of the examples of recent graduates from the Kirkby to have become important parts of the team at Anfield.
The club have adopted the strategy of recruiting some of the world's most promising youngsters to the academy, and it is clearly working.
Lewis Koumas, Trey Nyoni and Rio Ngumoha have all established themselves as important first-team squad players in the early days of Andoni Iraola's tenure at Anfield.

#first

Milan picked up a 3-2 victory over Atalanta on Sunday evening to keep their unbeaten start to the 2026-27 Serie A season alive, but newspapers in Italy have highlighted a 'growing problem' with the Rossoneri under recently-appointed head coach Ruben Amorim.
Milan were 3-0 up after an hour thanks to goals from Goncalo Ramos, Adrien Rabiot and Mario Gila in San Siro. Record signing Ramos had an opportunity to make it four from the penalty spot, but was unable to convert at the second time of asking.
ITALY – OCTOBER 18: Adrien Rabiot celebrates scoring his team's second goal with teammate Diego Moreira during the Serie A match between AC Milan and Atalanta BC at Stadio Giuseppe Meazza on October 18, 2026 in Italy. (Photo by Marco Luzzani/Getty Images)
From there, Atalanta began to grow back into proceedings, reducing the deficit through Gianluca Gaetano in the 66th minute and then again through Nikola Krstovic in the 81st. It was a nervous wait for the final whistle for Milan from there on in, with a few important saves from goalkeeper Mike Maignan to keep the victory intact.
Post-match reports from La Gazzetta dello Sport claim that Milan are 'on the right track' under Amorim, but a 'growing issue' has been identified. The Pink Paper suggests that Amorim's system simply demands too much from the Milan players on a physical level, which might explain why the team seem unable to keep the same level of performance for the full 90 minutes.

#atalanta #keep #adrien

Man United Women secured an impressive fifth consecutive win against Charlton Athletic Women on Sunday afternoon.
Goals from Ella Toone, Andrea Medina and Julia Zigiotti secured the three points for the Red Devils.
The result was significant not only because it allowed United to climb up to fifth in the WSL table, but also due to a crucial goal from Toone.
The England international's dipping effort went in underneath the crossbar and was her second goal of the season.
Nonetheless, it was her first goal of the WSL season and, incredibly, her first in the league since December last year.

#fifth

Enzo Maresca had predicted Phil Foden would score, and he did score. For much of Foden's career that would scarcely have seemed an outlandish prediction. Not now. Foden's had struck 27 times for Manchester City alone in 2023-24. Yet when Ipswich arrived at the Etihad Stadium on Saturday, his drought spanned 35 games for City, plus two for England that may have cost him a place at the World Cup.
But there are two Fodens. Maresca remembered the teenage prodigy, the player who had won the individual awards, the seeming generational talent before he became the goal-shy City substitute. "With Phil I said many times, I know him from years ago, for me he's one of the best Premier League players," said the City manager, who had worked with Foden in his previous times at the Etihad Stadium. "And since day one it's my duty to help him to again be one of the best players."
That process got off to something of a false start. By the time City kicked off against Ipswich Foden had, in effect, sat out four-and-three-quarter games. His first-half red card in the Manchester derby was followed by a three-match domestic suspension. He was an unused substitute in the Champions League defeat against Paris Saint-Germain.
Even before being banned, he had been usurped, and under successive managers. In first Pep Guardiola's valedictory season and then Maresca's first in charge, Rayan Cherki has been the No 10 who has starred and sparkled. Foden has provided less magic. Perhaps it says something for the luxuries Maresca enjoys that Foden has felt the more prosaic player in his position.
Perhaps it is an added complication, too, that in Enzo Fernandez he has costly competition emerging, with the £125m signing spending the second half against PSG operating as the most advanced of the midfield trio. A lesson of that defeat may be that, against elite opposition, Maresca requires both Ayyoub Bouaddi and Elliot Anderson to anchor the midfield, perhaps meaning Fernandez is the most advanced of the trio.

#perhaps #enzo #phil

Manchester United Women secured their fifth win of the season and their fifth consecutive victory against Charlton Athletic at The Valley on Sunday afternoon.
After a poor start to the season, United have roared back and their situation now appears much more positive.
United took the lead early on when Ella Toone scored a lovely looping effort to put her side in front.
The impressive Andrea Medina then added her second goal of the season with a first-time finish.
Charlton struck back, but Julia Zigiotti made sure of the points by finishing off an impressive move.

#charlton #impressive #manchester #women

Jets' Garrett Wilson reasons with stunningly quiet day in loss to Patriots appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
The New York Jets were unable to defeat the New England Patriots on Sunday. New York made it more of a game late than it had been in the first half. But in the end, they couldn't get anything going. A major reason for this was the rather quiet day from wide receiver Garrett Wilson.
For most of the game, Wilson wasn't targeted much. In fact, the ball went his way just twice before the fourth quarter. He ended the game with four catches and 44 yards on six targets. After the game, he spoke about the lack of action his way.
"I try and reason it in my head because we've got a whole nother fourth quarter and I know that the game can change at any moment. Just try and keep playing my role, waiting for that moment that they want to call on me," the Jets wide receiver said, via SNY Jets.
Watch sports LIVE with fuboTV (free trial)

#quiet #reason

New England Patriots WR A.J. Brown caught three of 10 targets for 27 yards in a Week 6 win over the New York Jets.
SOURCE: USA TODAY
Why It Matters: Brown, who hadn't played since injuring his ankle in the opener against Seattle (3-26-0), led the Pats with 10 targets, was understandably rusty and not on the same page as quarterback after missing a month. It may take some time for Drake Maye and Brown to find their rhythm, but it shouldn't be long until Brown is producing at a WR2 or WR1 level again. Consider Brown a high-end WR2 on a short week in Week 7 as the Patriots visit the Bears.
This article originally appeared on USA TODAY: A.J. Brown targeted 10 times in return vs. NY Jets

#week #targets

New England Patriots QB Drake Maye completed 18 of 32 passes for 235 yards with three touchdowns in a Week 6 win over the New York Jets. He added 24 yards on four rushing attempts.
SOURCE: USA TODAY
Why It Matters: Maye now has 10 touchdown passes against one interception with 878 yards in the last three games. He had one TD pass and six picks in the first three games. It's safe to say that Maye has regained his status as a QB1 and is looking like the quarterback who led the Patriots to the Super Bowl last season. He needs to be locked into lineups in Week 7, even on a short week with a visit to Chicago coming on Thursday.
This article originally appeared on USA TODAY: Drake Maye throws for another three scores in Week 6

#three #drake #last

Caleb Williams' injury return proves Bears can still win NFC North despite debacles vs. Packers, Vikings appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
Coach Ben Johnson's Chicago Bears got back on the winning track with a 31-23 win over the Atlanta Falcons at Mercedes-Benz Stadium that had coach Ben Johnson breaking out a new dance move. Williams broke a Bears record held by Mitchell Trubisky as he lit up the scoreboard against Kevin Stefanski's Dirty Birds.
Now 4-2 on the season, the Bears are firmly in the NFC North Division chase alongside three potential playoff teams: the undefeated Minnesota Vikings, Green Bay Packers and Detroit Lions.
Things looked grim after a 31-7 waxing at the hands of the Packers in Week 5, but the Bears are back in business after Williams' latest gem of a performance. A Thursday Night Football game against the Patriots could be just the stage Williams and the Bears need to show they are serious about contending for a Super Bowl again.
Watch sports LIVE with fuboTV (free trial)

#clutchpoints

Week 6 in the NFL has come and gone, and what a week it was! We saw some wild games across the league, with plenty of scoring, overtime, upsets- you name it! But what were the biggest fantasy football storylines to come from all that?
Caleb Williams is back! And back in a big way for the Bears, going 305/1/0 on 30 of 36 passes, in a win over the Atlanta Falcons. It also appears that Williams has reinvigorated the fantasy potential of Luther Burden and Colston Loveland, who were both off to mixed starts this season. It's also somewhat good to see that their defense is still terrible, which will only further boost Williams' production. They'll be forced into higher-scoring games, which is great for fantasy production.
So many of us want to believe that Kyle Pitts will be an elite tight end, but the lack of consistent production makes it tough to put him in our lineups every week. He's looked good over the last two weeks, but that's been bolstered by some touchdowns. Drake London still leads the team in target share, but if Michael Penix is willing to look to Pitts in the red zone, the touchdown upside will be there for him. I continue to think that Pitts is a low-end TE1 on most weeks, given the overall offensive potential of the Falcons.
While it was only his second game this season, Omar Cooper Jr. looked great for the Jets. A big 103 yards on 6 receptions and one touchdown pushed him to the top of the box score against the Patriots. It's also nice to see him do this while Garrett Wilson was also playing for the Jets. However, the question becomes: is this sustainable? Once Breece Hall gets back to the Jets offense, their overall dynamic might change, but Cooper Jr. has a role right now.
Is Noel the key to the Texans offense? The run game certainly isn't great; we know how good Nico Collins is, but they are missing another element, and Noel is shaping up to be that answer. Coming into this week, he led the Texans with 17.5 yards per reception and 13.35 yards per target. He brought this into the matchup versus the Jaguars and ended with 4/107/1, which is certainly his ceiling outcome, but this is the third straight week he's had either 80-plus receiving yards or a touchdown.

#week #back

Patriots' Mike Vrabel gets honest about AJ Brown's rusty form in return from injury appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
The New England Patriots finally got their star wide receiver AJ Brown back on the field after missing over a month with an ankle sprain he suffered in the season opener. However, he was far from his best as he finished with just three catches on 10 targets for 27 yards with four drops. He also managed to drop an onside kick at the end of the game that the Pats still recovered to end the game.
Brown himself was critical of his poor performance after the game. Patriots coach Mike Vrabel was also honest with his ***** sment of his star receiver's return during the post-game press conference.
"I think he could've probably made a few more plays, come down with a few more plays. He's been out for a while. I know he wanted to do well for his football team. Unfortunately, it wasn't his best effort. I know that and he knows that. We have all the confidence in AJ to finish those plays," Vrabel said.
Watch sports LIVE with fuboTV (free trial)

#Patriots #brown #honest #return

Kylie Kelce revealed why she wouldn't put her daughters' faces on social media. Recently, the mom of four appeared on a podcast and discussed her kids' involvement in her online posts. Kelce revealed she didn't struggle with it when she had her first daughter, but things changed eventually. As the family grew famous, the doting mother decided not to show her children's faces online.
Kylie Kelce and Jason Kelce protect their daughters' privacy on social media. During the podcaster's appearance on Tay Lautner's podcast, "The Squeeze," Kelce opened up about online privacy for kids. She and the retired NFL player share four daughters, Wyatt, Elliotte, Bennett, and Finnley. They rarely feature in the couple's photos on Instagram.
Speaking of the same, the 34-year-old mom told Lautner that things changed when their family grew popular. "I post infrequently overall, and I post even less frequently about our children," she said.
"I didn't want to exclude them entirely, [but] I made it a point to stop putting their faces on my social media." Furthermore, she explained that Jason's retirement documentary became the "turning point" in their lives. It required the children to be on camera, which made her realize that people couldn't set boundaries for themselves. Hence, Kelce drew it for them.
"I feel really strongly about going forward just for their safety to not include them in anything," she said. According to her, their children's "safety" will always be their top priority. Kelce also admitted that she tries to be careful about what photos she posts online related to her kids. She worries about how they would react in the future when they search for it online.

#four

The government has spent at least $2.5 million on the ads.
President Donald Trump said Monday night that he will no longer use taxpayer funds to pay for a multimillion-dollar pro-Trump ad blitz ahead of the midterm elections, saying his super PAC will now pay for them.
While he dismissed criticism of the ads as "a rather standard thing to do," he said he had decided to run them on his own dime rather than that of the U.S. government in a post on his social media platform.
"I have decided to do the Patriotic Ads, among others, and pay for them myself, and with money I raised for MAGA, Inc," Trump wrote, referring to his super PAC.
The move comes after the U.S. government bankrolled a series of ads that aired nationally and heavily featured the president. One of the ads was a direct copy of a spot Trump's campaign ran in 2024.

#Trump #president #super #MAGA

Updated on: October 5, 2026 / 7:29 PM EDT / CBS News
President Trump said Monday he will start paying for the pro-Trump ads that have blanketed the airwaves in recent weeks with money raised by his super PAC, after his administration drew intense pushback for using public funds on the ads.
"The Radical Left is upset with the fact that I am taking Ads, which I consider to be a positive promotion for our Great U.S.A., and paying for them with U.S.A. money," the president wrote on Truth Social. "This is a rather standard thing to do but, rather than doing that, although nothing will make them happy, I have decided to do the Patriotic Ads, among others, and pay for them myself, and with money I raised for MAGA, Inc."
Emblazoned with the message "Paid for by the U.S. Government," the ads began popping up late last month on national cable and broadcast networks, including CBS, as the November midterm elections approach.
Several variations have aired, including one that features a recording of Mr. Trump saying, "We will defeat communism, socialism and Marxism in America," as photos of the president flash across the screen. Another recounts the U.S. capture of former Venezuelan President Nicolás Maduro.

#paying

Nicole Kidman's daughters are stepping out for fashion week.
This week, the Kidman ladies are in Paris to attend a string of fashion shows, with the Lioness actress' eldest actually working the runway, while her youngest stepped out in support.
The Oscar winner shares daughters Sunday, 18, and Faith, 15, with ex-husband Keith Urban, to whom she was married from 2006 to 2025.
Faith attended the Valentino show solo in support of her sister (@ Getty Images)
On Sunday, October 4, Faith stepped out solo for the Valentino "Antibiblioteca" Womenswear Spring/Summer 2027, for which each guest was asked to bring a book that would later be donated to a local library.

#sunday #nicole

Here is a look at the celebrities who attended Alessandro Michele's Valentino Antibiblioteca Spring 2027 show, with one notable absentee: Dakota Johnson, who was busy hosting Saturday Night Live this weekend.
Alexander Skarsgård and Zoey Deutch opted for the same Valentino animal print, but on very different coats.
Alexander loves looks that don't necessarily make sense, so his decision to pair his leopard-print coat with a pale-pink top, purple sweatpants and black loafers makes sense, ironically – but only on him. Zoey's version was far more cohesive, with the fur-trimmed coat and embellished bag making the print feel especially luxurious.
Hande Erçel and KUN approached Valentino plaid from opposite directions. We know Hande best for the glamorous gowns she wears at Cannes and Bvlgari events, so seeing this more relaxed side of her style is refreshing. KUN's plaid tweed jacket was considerably sharper, with the sculpted shape and gold **** ons giving his look a more dressed-up feel.
Jeff Satur and Joe Alwyn both made a case for Valentino bomber jackets. Jeff's red version naturally commanded more attention, while Joe kept things considerably more subdued, as we would expect from him.

#hande #plaid

Leanna Lenee has quietly become just as much of a gameday fixture as her husband, Jacksonville Jaguars cornerback and wide receiver Travis Hunter, and once again, she gave fans exactly what they show up for.
Ahead of the Jacksonville Jaguars' matchup against the Cincinnati Bengals, Leanna stepped out in a custom teal-and-blue halter top emblazoned with "HUNTER" and the number 12 across the chest, paired with sleek black high-waisted pants featuring a cutout detail along the thigh. Her son matched her look almost piece for piece, dressed in a mini Jaguars romper carrying his father's name and number on the back. Leanna captioned the post simply: "Next question."
That two-word caption did little to slow down the response. However, this isn't the first time Leanna's gameday look has taken over the timeline either. Just weeks earlier, ahead of Jacksonville's matchup against the New England Patriots, she turned heads in a dusty blue bodycon dress covered in Jaguars patches, a jersey-number detail, and white cowboy boots, once again dressing her son in a coordinating fit down to the shoes. Fans' response then was nearly identical, with one commenter telling her outright she had "the cutest NFL wifey clothes," a sentiment that's clearly carried straight through to this latest appearance.
There was also plenty happening on the football side for the Hunter family to celebrate.
Fashion moments off the field are stealing the spotlight as much as the action on it. Subscribe to stay updated on the personalities and style that define NFL gamedays.

#jaguars #number #fans #ahead

New England Patriots rookie tight end Eli Raridon and his wife Anna are mourning the loss of their newborn son.
On Tuesday (September 29), Anna took to Instagram to share the news, revealing that the baby, Peter James Raridon, had died shortly after his birth earlier this month.
"Our angel, Peter James Raridon, was born on September 11th," she began her post. "When Eli and I went in for our 20-week anatomy scan, excited to see our sweet baby boy, our hearts were forever changed. Our little one was diagnosed with anencephaly, a fatal condition in which he would not survive outside the womb."
COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what's next. Buy. Collect. Obsess.
"While we are absolutely devastated that we were unable to bring our baby boy home, I am grateful to have loved him deeply, kept him safe, and had been his home for the past 9 months before he was called back to Heaven," she continued.

#peter #shop #home

Gray hair is gorgeous, and many famous women are increasingly rocking their silver crowns with pride. Many celebrities look stunning with gray hair, and it's so inspiring to see them embrace this natural part of aging. But another trend is popping up that we love even more: celebrity women over 50 who are wearing their hair long! So often, society pressures mature women to chop their hair once they reach a certain age (on top of the pressure to cover up their gray, too), so seeing these celebs rock both gray and long hair is truly beautiful.
Olivia Colman debuted long gray curls at the Zurich Film Festival on September 28, 2026. "The Crown" actor's gorgeous tresses fell long past her shoulders. Since Colman previously had a pixie cut, her stylist, Inanch Emir, helped her create the look with extensions. "We weren't trying to hide her grey hair — we wanted to celebrate it," Emir told InStyle in September 2026, adding that her extensions were a combination of four different shades of gray "to create depth and dimension and to work harmoniously with Olivia's own hair." The result was so incredibly natural-looking and so pretty on her.
Colman's hair is part of a growing trend of celebrity women who are both embracing gray and wearing their hair long at the same time. We are huge fans of women who defy social expectations with their beauty like this — and look so good doing it!
Read more: The Transformation Of Sam Elliott: From '70s Heartthrob To Landman Icon
Gilbert Carrasquillo & Gilbert Carrasquillo/Getty

#long #colman #september

It's been a disappointing couple of years for shareholders of biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP). This stock's barely up since the end of 2022, lagging the broad market's gains. It's not the performance that investors keeping tabs on this company were expecting, given its potential.
Don't be discouraged, though. While still speculative like most young biotech names, CRISPR Therapeutics remains a compelling prospect for investors who can stomach the risk and its inevitable volatility. Here's why.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
On the off-chance you're reading this and aren't already familiar with the company, CRISPR Therapeutics is a drug developer that specializes in gene editing.
It's probably an area you've heard a great deal about. No gene-editing drugs were actually on the market in the United States until CRISPR Therapeutics' Casgevy was approved by the FDA as a treatment for sickle cell disease in late 2023. Any and all gene therapies currently on the market followed this pioneer's foray. Being first is a well-deserved accolade for the company, too, which was co-founded by Dr. Emmanuelle Charpentier, who was one of the co-discoverers of the CRISPR/Cas9 gene-editing mechanism that makes Casgevy work.

#crispr #gene #company

Morgan Stanley met privately with Gilead Sciences (GILD) leadership at its 2026 Global Healthcare Conference this month, and the feedback strengthened the bank's positive view on the stock.
Morgan Stanley's biopharma team hosted a meeting and a management dinner with Gilead Chairman and CEO Daniel O'Day and Chief Commercial and Corporate Affairs Officer Johanna Mercier. According to a Morgan Stanley research note shared with me, the discussion reinforced its Overweight rating on Gilead and singled out one franchise as the biggest reason to stay positive.
Gilead trades around $150.89, up about 24% year to date and roughly 111% over five years. That kind of run in a biotech stock usually needs a catalyst, and Morgan Stanley points to HIV prevention. The bigger question for investors now is whether the new HIV prevention business built around Yeztugo can keep growing at the pace of the last few quarters.
Terence Flynn, a Morgan Stanley equity **** yst who covers Gilead and other healthcare stocks has held an Overweight rating on the stock since January 2025.
According to the note, Gilead management described the company as being at "an important inflection point, supported by what it views as the most robust portfolio in the company's history," with no patent expiring until 2036.

#gilead #healthcare #management #note

Interested in Axsome Therapeutics, Inc.? Here are five stocks we like better.
Auvelity remains Axsome's main growth driver: It generated more than $180 million of the company's $218.4 million in second-quarter revenue, while its new Alzheimer's disease agitation indication is supported by an expanded sales force of more than 600 representatives.
The commercial portfolio is expanding: Sunosi continues to grow, and SYMBRAVO revenue increased 30% sequentially in the second quarter as Axsome expanded its migraine sales team.
Pipeline and finances are strengthening: Axsome has several late-stage programs and upcoming clinical milestones, ended the quarter with $320 million in cash, and said it is approaching cash-flow positivity.
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out

#second

Celsius Holdings (NASDAQ: CELH) has had a rough year. The energy drink brand has plunged by almost 40% this year, but key insiders have been buying the dip. Celsius' CEO and two of its directors have poured almost $2 million into the stock this month.
When insiders buy the stock, it's often a good sign. The people with the most knowledge about the company are building their positions, but that hasn't always worked out for investors. Here's what you should know before joining Celsius' executives with their recent buys.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ****** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Although it's good to see executives put their skin in the game, it doesn't always translate into a higher stock price. For instance, Nike CEO Elliott Hill bought more than $2 million worth of Nike shares on April 13. Former Apple CEO Tim Cook made a similar investment in the beleaguered athletic apparel brand at the same time.
Nike shares have dropped by more than 15% since Hill invested more money. The athletic brand pitches itself as a "growth company" on its investor relations site, even though sales dropped 1% year over year in the fourth quarter of fiscal 2026.

#celsius #almost

On September 8, 2026, Reuters reported that NIKE, Inc. (NYSE:NKE) shareholders rejected a proposal urging greater transparency on how the company plans to meet its 2030 emissions-reduction targets, despite support from Norway's sovereign wealth fund, Nike's 11th-largest shareholder.
Nike's board had urged a "no" vote, arguing management is "best positioned to determine the targets and related disclosures that are appropriate." Shareholders separately approved the company's executive compensation proposal, including pay for CEO Elliott Hill, in a vote that had faced some opposition.
The failed climate proposal gives NIKE, Inc. (NYSE:NKE)'s management more flexibility to focus on its operational turnaround. Shareholders rejected the request for greater disclosure on how Nike plans to meet its 2030 emissions targets. It allows CEO Elliott Hill and his team to prioritize product innovation, sales recovery, and market-share gains. Nike faces significant operational challenges. So management could benefit from directing more resources toward restoring growth and profitability.
Nike has already made measurable progress toward its environmental targets. It limits the immediate financial impact of the rejected proposal. The company reported an 11% reduction in supply-chain emissions from its 2015 baseline in fiscal 2024, while its 2030 targets call for a 65% reduction in operational emissions and a 30% reduction across its supply chain. This progress gives Nike evidence that it is chasing its climate goals even without expanding its current disclosure.
Shareholders' approval of Elliott Hill's compensation package shows support for Nike's leadership despite the difficult turnaround. Investors approved more than $36 million in total compensation for Hill for fiscal 2026, even though Norway's wealth fund and major proxy advisers opposed the package. Shareholder support gives Hill greater room to execute his strategy as Nike works to stabilize sales, rebuild its market position, and restore long-term earnings growth.

#reduction #elliott #greater

A question has bedeviled a wealthy Lake Tahoe enclave for years: Who is poisoning the towering trees that stand sentry on the North Shore?
Residents of Incline Village, Nev., hope a $147,000 reward will generate some answers.
"It's the most appalling, selfish thing that anyone could do, especially for trees that are irreplaceable," said Chris Nolet, a retired certified public accountant and consultant to the biotechnology industry who ***** embled a small group of private donors known as Friends of Burnt Cedar Beach to put up the bulk of the reward. "These trees are 100 years old."
The donors are offering $122,000 for information leading to the successful prosecution of anyone responsible. The Incline Village General Improvement District, which owns and manages the residents-only beach where the poisonings took place, has put up another $25,000 and installed additional cameras around the trees.
The move came after an investigation failed to generate actionable leads, Nolet said.

#incline #nolet #beach #anyone

Parnassus Investments, an investment management company, released the "Parnassus Growth Equity Fund" second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index's 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services and Financials holdings detracted. For the year-to-date period, the Fund returned 6.17% (net of fees), outperforming the Russell 1000 Growth's 5.33%. The firm remains constructively bullish on U.S. equities and continues to be selective, valuation-sensitive, and focused on disruptive growth opportunities through active stock selection. Growth stocks advanced during the second quarter, as the Russell 1000 Growth Index generated strong double-digit returns driven by increased confidence in the durability of the ongoing artificial intelligence (AI) infrastructure build-out. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Parnassus Growth Equity Fund highlighted Insmed Incorporated (NASDAQ:INSM). The Fund exited its position in Insmed Incorporated (NASDAQ:INSM), a clinical-stage biotechnology company that develops and commercializes therapies for patients with serious and rare diseases, during the quarter. On September 15, 2026, Insmed Incorporated (NASDAQ:INSM) closed at $119.92 per share. Over the past month, Insmed Incorporated (NASDAQ:INSM) declined 7.49%, but its shares are down 16.51% over the past year. Insmed Incorporated (NASDAQ:INSM) has a market capitalization of $26.19 billion, and its stock has traded within a 52-week range of $90.39 and $212.75.
Parnassus Growth Equity Fund stated the following regarding Insmed Incorporated (NASDAQ:INSM) in its Q2 2026 investor letter:
"Insmed Incorporated (NASDAQ:INSM)shares fell after sales of the biopharmaceutical company's new lung drug Brinsupri fell short of ****** ysts' expectations. We exited the position during the quarter. Insmed's thesis had largely played out following positive TPIP data and upward revisions to Brinsupri sales. We redeployed capital to Twist Bioscience, which offers a longer runway for growth."
Insmed Incorporated (NASDAQ:INSM) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 88 hedge fund portfolios held Insmed Incorporated (NASDAQ:INSM) at the end of the second quarter, compared to 67 in the previous quarter. While we acknowledge the potential of Insmed Incorporated (NASDAQ:INSM) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

#Growth #parnassus

Parnassus Investments, an investment management company, released the "Parnassus Growth Equity Fund" second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index's 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services and Financials holdings detracted. For the year-to-date period, the Fund returned 6.17% (net of fees), outperforming the Russell 1000 Growth's 5.33%. The firm remains constructively bullish on U.S. equities and continues to be selective, valuation-sensitive, and focused on disruptive growth opportunities through active stock selection. Growth stocks advanced during the second quarter, as the Russell 1000 Growth Index generated strong double-digit returns driven by increased confidence in the durability of the ongoing artificial intelligence (AI) infrastructure build-out. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Parnassus Growth Equity Fund highlighted Twist Bioscience Corporation (NASDAQ:TWST) as a new addition. Twist Bioscience Corporation (NASDAQ:TWST) is a leading biotechnology company specializing in the manufacture and sale of synthetic DNA-based products. On September 15, 2026, Twist Bioscience Corporation (NASDAQ:TWST) closed at $138.10 per share. Over the past month, Twist Bioscience Corporation (NASDAQ:TWST) returned 2.97% while its shares gained 443.64% over the past 52 weeks. Twist Bioscience Corporation (NASDAQ:TWST) has a market capitalization of $9.09 billion and its stock has traded within a 52-week range of $23.30 and $155.44.
Parnassus Growth Equity Fund stated the following regarding Twist Bioscience Corporation (NASDAQ:TWST) in its Q2 2026 investor letter:
"During the quarter, we added Twist Bioscience Corporation (NASDAQ:TWST), a biotechnology company with a proprietary silicon-based DNA synthesis platform. Twist Bioscience provides exposure to two powerful long-term trends in Health Care, AI-supported drug discovery and next-generation sequencing. The company's proprietary silicon-based DNA synthesis platform enables higher throughput and lower costs than traditional methods, creating a durable competitive advantage and positioning Twist to take share in a growing market."
Twist Bioscience Corporation (NASDAQ:TWST) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 42 hedge fund portfolios held Twist Bioscience Corporation (NASDAQ:TWST) at the end of the second quarter which was 30 in the previous quarter. While we acknowledge the potential of Twist Bioscience Corporation (NASDAQ:TWST) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands

Biogen Inc. (BIIB) is a global biotechnology company that develops and commercializes therapies for serious and complex diseases. Headquartered in Cambridge, Massachusetts, Biogen has built a strong presence in neurology, specialized immunology, and rare diseases, with a portfolio spanning multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, ALS, and other conditions.
Companies worth $10 billion or more are typically classified as "large-cap stocks," and Biogen, with a market cap of $32.1 billion, fits the label perfectly. Biogen's core strength lies in its deep neuroscience expertise and a portfolio of established therapies for complex neurological and rare diseases. Its long-standing research capabilities, specialized commercial infrastructure, and broad pipeline also provide scale and expertise that smaller biotech rivals can find hard to replicate.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
Nvidia CEO Jensen Huang Just Dropped Huge News for This Cybersecurity Stock
How to Play GME Stock as GameStop CEO Ryan Cohen Buys $20.3 Million in Shares

#biogen #complex #expertise